
saquinavir oral brand names and other generic formulations include:
eletriptan hbr oral brand names and other generic formulations include:
saquinavir oral and eletriptan hbr oral
saquinavir oral increases levels of eletriptan hbr oral by altering drug metabolism. Combination increases risk of side effects. Not recommended for use within 72 hours of potent CYP3A4 inhibitors.
saquinavir oral and eletriptan hbr oral
saquinavir oral increases levels of eletriptan hbr oral by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Potential for increased toxicity. Contraindicated for use within 72 hours of potent CYP3A4 inhibitors.
Check for more interactions with the Drug Interaction Checker
Drug Interaction Categories
Contraindicated
Never use this combination of drugs because of high risk for dangerous interaction
Serious
Potential for serious interaction; regular monitoring by your doctor required or alternate medication may be needed
Significant
Potential for significant interaction (monitoring by your doctor is likely required)
Minor
Interaction is unlikely, minor, or nonsignificant